FARGNOLI, MARIA CONCETTA
 Distribuzione geografica
Continente #
NA - Nord America 8.714
EU - Europa 4.978
AS - Asia 2.244
Continente sconosciuto - Info sul continente non disponibili 19
SA - Sud America 16
OC - Oceania 11
AF - Africa 3
Totale 15.985
Nazione #
US - Stati Uniti d'America 8.699
IE - Irlanda 1.831
CN - Cina 1.048
TR - Turchia 827
SE - Svezia 776
DE - Germania 552
UA - Ucraina 477
GB - Regno Unito 431
IT - Italia 369
SG - Singapore 253
FI - Finlandia 235
FR - Francia 131
CZ - Repubblica Ceca 49
IN - India 42
BE - Belgio 40
VN - Vietnam 37
ES - Italia 26
EU - Europa 18
RU - Federazione Russa 15
AU - Australia 10
CA - Canada 8
KR - Corea 8
NL - Olanda 7
IL - Israele 6
TW - Taiwan 6
BR - Brasile 5
HU - Ungheria 5
ID - Indonesia 5
RS - Serbia 5
JP - Giappone 4
LU - Lussemburgo 4
MX - Messico 4
PE - Perù 4
AR - Argentina 3
MK - Macedonia 3
PL - Polonia 3
RO - Romania 3
AL - Albania 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
MD - Moldavia 2
ME - Montenegro 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
HK - Hong Kong 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
MM - Myanmar 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 15.985
Città #
Chandler 1.944
Jacksonville 1.918
Dublin 1.829
Boardman 691
Izmir 422
Nanjing 335
Lawrence 306
Princeton 306
San Mateo 304
Wilmington 297
New York 252
Singapore 161
Ann Arbor 156
Ashburn 152
Milan 121
Woodbridge 113
Nanchang 108
Des Moines 86
Mountain View 80
Shenyang 73
Seattle 67
Beijing 64
Los Angeles 59
Tianjin 57
Hebei 55
Verona 54
L'aquila 50
Falls Church 48
Brno 45
Kunming 42
Jiaxing 41
Brussels 40
Jinan 39
Munich 39
Dearborn 37
Dong Ket 35
Norwalk 34
Dallas 32
Helsinki 31
Ningbo 29
Changsha 25
Shanghai 20
Zhengzhou 20
Bremen 18
Fremont 17
Pune 17
Changchun 16
Hangzhou 15
Taizhou 15
Rome 14
Guangzhou 13
Tappahannock 13
Houston 12
Lappeenranta 11
Philadelphia 11
Redwood City 11
Pescara 10
Auburn Hills 9
Lanzhou 9
Redmond 8
Chapel Hill 7
Edinburgh 7
Lissone 6
London 6
Madrid 6
Santa Clara 6
Budapest 5
Hefei 5
Hyderabad 5
Jakarta 5
Nancy 5
Phoenix 5
San Francisco 5
San Michele All'adige 5
Taipei 5
Berlin 4
Bologna 4
Fairfield 4
Luxembourg 4
Scuola 4
Stockholm 4
Amsterdam 3
Belgrade 3
Cedar Knolls 3
Forest City 3
Frankfurt am Main 3
Grafing 3
Haikou 3
Lima 3
Menlo Park 3
Mumbai 3
Olomouc 3
Paris 3
Tokyo 3
Washington 3
Bari 2
Belpasso 2
Bolzano Vicentino 2
Centrale 2
Cepagatti 2
Totale 10.995
Nome #
Cutaneous metastatic breast carcinoma: A study of 164 patients 184
Rapid response of scalp psoriasis to ustekinumab 98
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 86
Cutaneous manifestations in Italian kidney transplant recipients 83
Dermoscopic features of actinic keratosis 82
Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp 82
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 82
Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy 80
Mucosal involvement in a patient with lymphomatoid papulosis 80
Staging and follow-up of cutaneous Melanoma patients 80
Efficacy, tolerability and cosmetic acceptabilily of Toléderm® in patients with inflammatory cutaneous diseases of the face 79
T-cell receptor (TCR) signal transduction: Biochemical mechanisms and possible clinical implications 79
Parapsoriasi 79
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 79
The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative 79
Diminished TCR signaling in cutaneous T-cell Iymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk 78
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant 78
Reduced expression of CDKN2a/p16INK4a in mycosis fungoides 76
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 76
Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population 75
Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis 75
MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair 75
Pigmented reticular structures in basal cell carcinoma and collision tumours 74
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family 74
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis 73
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study 73
A variant in FTO shows association with melanoma risk not due to BMI 73
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity 73
Acneiform follicular mucinosis of the head and neck region 72
Rationale for the development of speckled hyperpigmentation in the areas of psoriatic plaques after treatment with biologic agents 72
Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis 71
DIMINISHED ACTIVITY OF MEMBRANE-BOUND P50(CSK) IN CUTANEOUS T-CELL LYMPHOMA 71
Strategy for in vitro and ex-vivo testing of neutrophins signaling pathways based on immunoproteomic array profiling 71
Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system 71
Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location 71
Molecular genetic aspects of cutaneous melanoma 70
Treatments of advanced basal cell carcinoma: a review of the literature 70
Use of recombinant interferon alpha-2a in the treatment of squamous cell carcinoma 70
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families 70
EDNRB gene variants and melanoma risk in two southern European populations. 70
Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features 69
CDKN2A/p16 expression in mycosis fungoides 69
Pilotropic mycosis fungoides presenting as an acneiform eruption 69
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy 69
Unusually large cutaneous metastases of renal cell carcinoma 69
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 69
Knowledge of melanoma and attitude towards moles in Italian melanoma 69
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy 69
MC1R Variants Increase Risk of Melanomas harboring BRAF Mutations 69
Cutaneous metastases of gastrointestinal malignancies 68
Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype 68
Mycosis fungoides. Clinical and molecular biology observations 68
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysis 68
CDKN2A alterations in patients with multiple primary melanomas 68
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy 68
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma 68
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 68
Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis 67
Dermoscopic features and follow-up changes of acral melanocytic naevi in childhood and dolescence. 67
Pentachrome vitiligo 67
CDKN2A methylation as a predisposing factor for familial melanoma 67
The CDKN2A A148 T variant is not associated with melanoma risk in the French and Italian populations 67
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 66
Granulomatous mycosis fungoides responsive to gemcitabine 66
Dermoscopic features of facial pigmented actinic keratosis 66
On the interplay of telomeres, nevi and the risk of melanoma 66
Photodynamic therapy for basal cell carcinoma 66
Imiquimod treatment of superficial and nodular basal cell carcinoma: a 12-week open label trial 66
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project 65
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics. 65
Gli Interferoni 65
Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R 65
Figurate eruption in a 69-year-old woman 64
Germline and somatic CDKN2A mutations in multiple primary melanoma patients. 64
Teledermoscopic evaluation of 50 cases of pigmented skin lesions stored with 3 different resolutions 64
CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds 64
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 64
Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna 64
Eruptive xanthomas as revealing sign of type V hyperlipoproteinemia in a patient with a psychotic syndrome 63
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 63
Topical tazarotene 0.05% versus glycolic acid 70% treatment in a patient with X-linked ichthyosis 63
Figurate eruption: Erythema annulare centrifugum, deep type 63
The spectrum of dermatoscopic patterns in blue nevi 62
High-penetrance melanocortin 1 receptor gene variants contribute to sporadic cutaneous melanoma risk in the Italian population 62
Dermoscopic changes of Spitz/Reed nevus in childhood 62
Efficacy of tetracycline treatment to prevent the acneiform eruption secondary to cetuximab therapy 62
Photodynamic therapy for the treatment of micro invasive squamous cell carcinoma of the lower lip: a case report 62
No evidence for linkage with melanoma in Italian melanoma-prone families 61
Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma 61
Psoriasi 61
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study 61
Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients 61
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments 61
Peripheral nervous system involvement in a patient with large T-cell lymphoma arising from a pre-existing mycosis fungoides 60
Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial 60
Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk 60
Hypo-epiluminescence microscopy of pigmented skin lesions. A new approach to improve recognition of dermoscopic structures 60
CONSTITUTIONAL AND ENVIROMENTAL RISK FACTORS FOR CUTANEOUS MELANOMA IN ITALIAN POPULATION. A CASE-CONTROL STUDY 60
The biology of melanoma 60
Efficacia e tollerabilità della terapia fotodinamica con 5-metil-aminolevulinato nel trattamento del carcinoma basocellulare 60
Totale 7.042
Categoria #
all - tutte 76.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.493 0 0 220 16 16 251 405 33 264 30 9 249
2020/20212.189 15 246 2 252 241 92 304 68 289 99 452 129
2021/20221.694 96 128 308 108 56 39 23 104 175 17 131 509
2022/20235.428 394 290 94 546 454 608 4 399 2.354 31 173 81
2023/20241.400 210 67 147 204 88 355 42 52 1 64 32 138
2024/2025691 167 108 416 0 0 0 0 0 0 0 0 0
Totale 16.450